click below
click below
Normal Size Small Size show me how
Lung Tmt
Therapy for Lung/Pleura Tumors
| Question | Answer |
|---|---|
| Tmt for NSCLC (non-small cell lung carcinoma) ? | * based on receptor mutations in ALK, ROS1, and EGFR |
| If no mutations ? | * Systemic cytotoxic chemotherapy ...... * Cisplatin or carboplatin based regimen often in combination with bevacizumab |
| Nomenclature... “mab” ? | * monoclonal antibodies |
| “ximab” ? | * chimeric monoclonal antibodies |
| “mumab” ? | * humanized monoclonal antibodies |
| “tinib” ? | * tyrosine kinase inhibitors |
| “zomib” ? | * proteasome inhibitors |
| Bevacizumab ? | * Targets all forms of vascular endothelial growth factor A (VEGF-A), which prevents vascular proliferation |
| Bevacizumab Side Effects ? | * Black Box for GI perforations and Hemorrhaging..... can also cause thrombuses, HF, HTN, Necrotizing Fascitis |
| Erlotinib ? | * Use: NSCLC--First-line therapy in patients with EGFR mutations..... * Tyrosine Kinase Inhibitor--- Selectively and reversibly inhibits the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) |
| Erlotinib Side Effects ? | * Pulmonary issues, skin blistering, diarrhea, and eye issues |
| Crizotinib ? | * Use: metastatic NSCLC ----for anaplastic lymphoma kinase (ALK)-positive tumors..... * Tyrosine Kinase Inhibitor |
| Crizotinib Side Effects ? | * Bradycardia, hepatotoxicity, occular toxicity, pulmonary issues and Prolong QT interval |